Efficacy of a Rehabilitation Program With the Pediatric Exoskeleton ATLAS 2030 in Pediatric Patients With Cerebral Palsy

Last updated: September 26, 2024
Sponsor: MarsiBionics
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Cataplexy

Cerebral Palsy

Treatment

ATLAS 2030

Clinical Study ID

NCT05926635
SERMAS
  • Ages 3-14
  • All Genders

Study Summary

Cerebral Palsy (CP) is the first cause of motor disability in children worldwide. ATLAS 2030 is a robotic gait exoskeleton designed to rehabilitate children with motor disability. The objective of this study is to analyse the efficacy of a training program with ATLAS 2023 in chilren with CP.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Medical authorization for standing, gait training and weight bearing.

  • Informed consent signed by legal guardians.

  • Confirmed diagnosis of cerebral palsy GMFCS levels III or IV.

  • Proper family acceptance and commitment level.

  • Receiving a minimum of 2 hours of therapy/activities promoting physical activity.

  • Maximum user weight of 35 kg.

  • Hip width (between greater trochanteres) less than or equal to 35 cm.

  • Length of the thigh (distance from the greater trochanter to the lateral condyle ofthe tibia) from 24cm to 33cm.

  • Tibia leg length (distance from the lateral condyle of the tibia to the lateralmalleolus) from 23cm to 32cm.

  • Shoe size 27-33 (EU)

Exclusion

Exclusion Criteria:

  • More than 8 sessions of robotic therapy during a month in the previous year to thebeginning of the study.

  • Intensive rehabilitation during the study.

  • Imposibility of the family to fulfill treatment calendar.

  • Spasticity equal to 4 on the Modified Ashworth Scale at the time of use of thedevice.

  • More than 20º of hip and/or knee flessum at the time of using the exoskeleton.

  • Necessity to walk with 10º of hip abduction.

  • Necessity to walk with more than 9º of ankle dorsiflexion or plantar flexion orimpossibility to use an orthosis to reach 90º in the ankle joint.

  • Severe skin lesion on parts of the lower extremities that are in contact with thedevice.

  • Scheduled surgery (rachis, limbs) for the duration of the study or surgery performed (rachis, extremities) in the last 6 months.

  • History of fracture without trauma. History of bone fracture traumatic in lowerextremities or pelvic girdle in the last 3 months.

  • Severe rigid orthopedic deformities of the spine and/or lower limbs.

  • Cognitive or conductual disorders that may lead to a lack of adherence to theattachment to the device.

  • Conditions that provoke exercise intolerance.

  • Conductual disorders that may interfere with the use of the device or theirparticipation in the study, like impulsiveness or the inability to understand simplecomands.

  • Allergy to any of the ATLAS materials: cotton, nylon, polyester, polyamide,polyethylene or propylene.

Study Design

Total Participants: 60
Treatment Group(s): 1
Primary Treatment: ATLAS 2030
Phase:
Study Start date:
August 03, 2023
Estimated Completion Date:
May 11, 2025

Study Description

A sample of children with CP will be divided into 2 groups, the experimental group will receive 32 sesions withe the ATLAS 2030 exoskeleton, whereas the control group will continue to receive their regular conventional therapy. Assessments will be performed at the beginning and the end of the intervention, as well as after 6, 9 and 12 months of the end of the intervention for follow-up.

Connect with a study center

  • Hospital Infantil Universitario Niño Jesús-Servicio de Rehabilitación

    Madrid, 28009
    Spain

    Site Not Available

  • Hospital Universitario 12 de Octubre

    Madrid, 28041
    Spain

    Site Not Available

  • Hospital Universitario Gregorio Marañón

    Madrid, 28007
    Spain

    Site Not Available

  • Hospital Universitario La Paz

    Madrid, 28046
    Spain

    Site Not Available

  • Hospital Universitario Niño Jesús-Servicio de Neuro Ortopedia

    Madrid, 28009
    Spain

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.